Ceribell delivers clinically meaningful diagnostic information in the acute care setting

As your front-line STAT and 24-hour continuous EEG solution, Ceribell allows you to prioritize your time and use of conventional EEGs for the right patients

Time to EEG Matters

Even a two-hour delay in time to EEG can reduce response to first-line treatment by half.1 The longer the duration of seizure, the higher the mortality.2 Unlike stroke or cardiac arrest, most hospitals lack protocols to rapidly diagnose non-convulsive status epilepticus.

Treatment Response Rate1

Time in Seizure is Associated with Increase in Mortality2

Guidelines Recommend Timely EEG to Detect and Manage Seizures

“Continuous EEG monitoring should be initiated within 1 h of SE onset if ongoing seizures are suspected.”

NCS Guidelines for the Evaluation and Management of Status Epilepticus3

“Recommend promptly performing and interpreting EEG for the diagnosis of seizures in patients who do not follow commands after ROSC.”

AHA Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care4,5

Conventional EEG: Not Designed for Critical Care

It can take hours, or even days, to administer and interpret a conventional EEG in the critical care setting6-9, but neurological emergency patients can’t wait.​

  • Designed for outpatient & epilepsy evaluation
  • Delays care due to wait times for EEG techs
  • Limited after-hours availability
  • Diverts resources from patients needing routine EEG studies

The lack of immediate, actionable brain monitoring at the bedside leaves clinicians facing a difficult decision: wait for an EEG and the neurology read, or treat based only on clinical suspicion.

Ceribell Point-of-Care EEG:
Built for Critical Care. Designed with Neurologists.

  • Designed for emergency and critical care
  • Real-time seizure burden monitoring
  • Alerts for suspected status epilepticus based on NCS and ACNS definitions
  • Enables rapid bedside EEG in minutes6
  • No EEG tech required for setup
  • Supports fast triage and diagnosis

Ceribell® Indications, Safety & Warnings

Ceribell POC EEG

Conventional EEG

Simplicity Matters When Time is Brain

Ceribell offers equivalent signal quality to conventional EEG12

Ceribell has the optimal number of electrodes for seizure rule in and out

<1% of EEGs showed parasagittal seizures, all of which were visible in temporal channels and thus would be captured on Ceribell montage13

95% concordance diagnosis or ruling out of seizure activity between conventional and reduced montage like Ceribell14

In an emergency, you don’t need a full montage to know why a patient is aphasic.

No Added Hospital-Acquired Infections (HAIs) Risk with​ Ceribell

Disposable electrodes eliminate the need for electrode cleaning, disinfection or sterilization, greatly simplifying clinical workflows while delivering superior patient safety and institutional protection.

In addition to serious clinical implications, HAIs pose significant financial burdens on health systems, including:

Higher treatment cost15
Longer hospital stays15
Increased risk of mortality15
Regulatory penalties16

Performance You Can Trust

Clarity is validated to consistently alert for suspected status epilepticus and rule out seizure – on par with top epileptologists.​17,18

Learn More

The Ceribell Advantage

Intuitive, Secure Portal

Ceribell meets the highest cybersecurity standards and is one of only 51 companies to have FedRAMP High authorization from the VA*

Native AI Integration

Clarity was developed using Ceribell hardware and using our continually expanding database of over 800,000 hours of expert-annotated EEG from ICU and ED patients.

Demonstrated Value

Only NTAP-eligible device offering up to $913.30 per eligible patient,11※ with proven length of stay and transfer reduction.19-22​

The Evidence Leader

Ceribell is backed by 35+ peer-reviewed publications from multi-center clinical studies,* including DECIDE6, SAFER-EEG19,23, and AccuRASE24.​

See Evidence

Adopted by 500+ Hospitals* & Endorsed by Epileptology Leaders

Ready to Transform Your Neurology Practice?

Don’t let conventional EEG limitations compromise patient care. See how Ceribell can integrate seamlessly into your emergency and critical care workflows.

Schedule Your Demo
Explore the EEG Portal
ICU patient with Ceribell

Ceribell for the ICUCeribell Pointer Icon

ED patient with Ceribell

Ceribell for the EDCeribell Pointer Icon

Ceribell for Neurology

Ceribell EEG PortalCeribell Pointer Icon

decorative

Resources

featured resources orange dot

The Ceribell EEG Portal makes it easy to quickly review EEGs in real-time on any device

Read More

PAGE

featured resources orange dot

Skill-building Webinar: Reading Ceribell EEG

Watch Our Webinar

Webinar

featured resources orange dot

Ceribell Signal Quality Manuscript: Signals Recorded With Rapid Response EEG And Conventional EEG Systems

Read More

In The News

References and Citations


1. Young, G.B., et al. (1996). Neurology, 47(1):83-89
2. Lowenstein, D.H., et al. (1993) Neurology, 43(3 Pt 1):483-488
3. Brophy, G., et al. (2012) Neurocrit Care. 17(1):3-23
4. Panchal, A.R., et al. (2020) Circulation. 142(suppl 2):S366-S468
5. Perman S.M., et al. (2023) Circulation 149(5):e254-e273
6. Vespa, P.M., et al. (2020) Crit Care Med. 48(9):1249-1257
7. Gururangan, K., et al. (2016) Clinical Neurophysiology. 127(10):3335-3340
8. Quigg, M., et al. (2001) J Clin Neurophysiol. 18(2):162-165
9. Gavvala, J., et al. (2014) Epilepsia. 55(11):1864-1871
10. FDA 510k Clearance Letter K223504
11. CMS FY 2024 IPPS Final Rule. CMS-1785-F, 88 Fed. Reg. 58927-58930, Aug. 28, 2023
12. Kamousi, B., et al. (2019) Clin Neurophysiol Practice. 4:69-75
13. Gururangan, K., et al. (2019) Neurocrit Care. 32(1):193-197
14. Westover, M.B., et al. (2020) Neurocrit Care. 33(2):479-490
15. Miller, M.A., et al. (2024) HCUP Statistical Brief #313
16. Wood, D.M., et al. (2024) Risk Manag Healthc Policy. 17:2181-2190​
17. Karunakaran, S., et al., (2024). AES2024 Annual Meeting Poster


18. Kamousi, B., et al. (2021) Neurocrit Care. 34:908-917
19. Desai, M., et al. (2025) Neurocrit Care. 42(1):108-117
20. Eberhard, E., et al. (2023) J Neurosci Nurs. 55(5):157-163
21. Madill, E.S., et al. (2022) Epileptic Disorders. 24(3):507-516
22. Ward, J., et al. (2023) Front. Digit. Health. 5:1035442
23. Kalkach-Aparicio, M., et al. (2024) Neurology. 103(2): e209621
24. Sheikh, Z., et al. (2024) Neurology 104 (2)

* As of June 2025
† At ≥ 90% seizure burden
‡ At 0% seizure burden for ruling out seizure and status epilepticu
※ For informational, illustrative purposes only. Not legal advice or financial guidance and not intended to increase or maximize reimbursement. Hospitals and HCPs are solely responsible for complying with Medicare and other payer policies. Ceribell does not guarantee reimbursement for the diagnosis of ESE, MS-DRG payment or NTAP eligibility. Contact Medicare contractor, reimbursement specialists, and/or legal counsel for interpretation of coding, coverage, and payment policies.